# Gov. Beshear Announces Medical Cannabis Updates and Scam Prevention > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/kentucky-medical-cannabis-regulations-scam-prevention/ > **Published:** 2026-03-10T07:06:38-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:59:41-04:00 > **Clinical Summary:** Learn about Kentucky medical cannabis regulations and the new scam prevention program protecting patients from fraudulent cannabis products. --- ✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. PolicySafetyIndustry Why This Matters Kentucky clinicians now need to understand the state’s new [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) regulations and patient protections to safely advise patients on legal access and avoid directing them toward unlicensed vendors. The new scamming prevention program indicates that patients are vulnerable to fraudulent cannabis products, making clinician education on legitimate dispensary verification essential for patient safety. As medical cannabis becomes legally available in Kentucky, clinicians should be prepared to discuss evidence-based [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) with patients while helping them navigate regulatory requirements and identify legitimate sources. Clinical Summary Kentucky’s legalization of medical cannabis in January 2025 has prompted Governor Beshear to implement consumer protection measures, including a new website and scam prevention program designed to combat fraudulent cannabis products and unlicensed vendors in the emerging market. This regulatory initiative reflects early recognition that rapid legalization without adequate consumer safeguards can expose patients to counterfeit or contaminated products, which poses direct risks to medication safety and therapeutic efficacy. The scam prevention program addresses a critical gap in the nascent Kentucky cannabis market where patients may lack reliable resources to verify product legitimacy or identify licensed dispensaries and practitioners. For clinicians counseling patients about medical cannabis in Kentucky, awareness of these state-level protections and the governor’s consumer education efforts can enhance discussions about where patients should obtain products and how to recognize fraudulent sellers. Clinicians should familiarize themselves with Kentucky’s official resources and recommend that patients use only state-verified sources to minimize exposure to contaminated or mislabeled products that could compromise treatment outcomes or cause adverse events. Directing patients to the state’s scam prevention website and official dispensary registries will help ensure they access legitimate, quality-controlled cannabis products aligned with their clinical recommendations. Dr. Caplan’s Take “What we’re seeing in Kentucky is exactly what happens when you legalize [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) without robust patient education and fraud prevention in place first: vulnerable people get scammed, lose money and trust, and cannabis itself gets blamed for the failures of implementation rather than policy design.” Clinical Perspective Kentucky’s recent legalization of medical cannabis and concurrent launch of patient-protection initiatives reflects a broader national trend toward regulated cannabis access, though healthcare providers should recognize that implementation timelines and regulatory frameworks vary significantly across states. The announcement of scam-prevention measures is particularly relevant clinically, as patients may be vulnerable to fraudulent products or unverified dispensaries during early rollout phases, potentially exposing them to contaminated or mislabeled cannabis with unpredictable cannabinoid content. Providers should remain vigilant about the limited long-term safety and efficacy data for most cannabis-derived therapeutics, especially given that many patients will have received cannabis information from non-clinical sources prior to seeking medical guidance. When patients inquire about [medical cannabis eligibility](https://cedclinic.com/rhode-island-medical-marijuana-card-qualifying-conditions/) or effects, clinicians should direct them to official state resources, document discussions thoroughly, and maintain awareness that evidence-based dosing and standardization remain nascent compared to FDA-approved medications. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Gov.+Beshear+announced+medical+cannabis+updates%2C+new+scamming+prevention+program+%40drcaplan&url=https%3A%2F%2Fwhopam.com%2F2026%2F03%2F09%2Fgov-beshear-announced-medical-cannabis-updates-new-scamming-prevention-program%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwhopam.com%2F2026%2F03%2F09%2Fgov-beshear-announced-medical-cannabis-updates-new-scamming-prevention-program%2F) [🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Gov.+Beshear+announced+medical+cannabis+updates%2C+new+scamming+prevention+program+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwhopam.com%2F2026%2F03%2F09%2Fgov-beshear-announced-medical-cannabis-updates-new-scamming-prevention-program%2F) [📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/) [📝 Read more on Substack](https://substack.com/@doctorapproved) [🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://whopam.com/2026/03/09/gov-beshear-announced-medical-cannabis-updates-new-scamming-prevention-program/](https://whopam.com/2026/03/09/gov-beshear-announced-medical-cannabis-updates-new-scamming-prevention-program/) Further Reading Cannabis Policy Wire[Policy Watch: 20 Regulatory Updates — March 10, 2026](https://cedclinic.com/dea-scheduling-synthetic-opioids-regulatory-updates-2026/) Evidence Watch[`Cannabinoid Clinical Trials: CBD Cortical Excitability Study`](https://cedclinic.com/cannabidiol-lacks-intrinsic-anti-epileptic-properties-trial/) Research Digest[Daily Digest 2026-03-07](https://cedclinic.com/adolescent-cannabis-psychiatric-outcomes-2026-digest/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Study Finds Licensed Cannabis Farms More Effective Than Bans in Deterring Unlicensed Cultivation](https://cedclinic.com/study-finds-licensed-cannabis-farms-more-effective-than-bans-in-deterring-unlicensed-cultivation/) Explore how licensed cannabis farms help reduce unlicensed cultivation, enhancing patient safety and market integrity. [Read the Study](https://cedclinic.com/study-finds-licensed-cannabis-farms-more-effective-than-bans-in-deterring-unlicensed-cultivation/) [Ohio SB 56 to Enforce Removal of Intoxicating THC Products from Unlicensed Retailers](https://cedclinic.com/ohio-cannabis-enforcement-sb-56/) Learn about Ohio’s legislative efforts to protect consumers by removing illicit THC products from the market. [Learn More](https://cedclinic.com/ohio-cannabis-enforcement-sb-56/) [Nebraska Bill to Protect Healthcare Practitioners Who Recommend Medical Cannabis](https://cedclinic.com/nebraska-healthcare-practitioner-protections-medical-cannabis/) Understand legal protections for healthcare providers recommending medical cannabis in Nebraska’s evolving regulatory landscape. [Explore the Bill](https://cedclinic.com/nebraska-healthcare-practitioner-protections-medical-cannabis/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).